Article: Improved drug delivery with precision particle fabrication
Posted: 8 June 2021 | ADARE Pharma Solutions | No comments yet
Improved drug delivery with precision particle fabrication-enabling precise control over particle structure.
In pharma delivery, size matters. So, too do the intricacies of dosage format, active ingredient compatibility and effective delivery to patients—whatever their needs or preferences may be.
When Adare Pharma Solutions acquired Orbis Biosciences what we were able to add is the ability to go even further down in particle size than before, and with greater uniformity, which translates into being able to include those particle sizes in different types of dosage forms.
Related content from this organisation
- Maintaining EU MDR certification: a spotlight on post‑market clinical follow-up
- Formulation, Development & Delivery In-Depth Focus 2021
- Scientific briefing: Formulation-Monodisperse CR quetiapine microspheres
- Scientific briefing: Formulation of aqueous core poly (lactic acid) microcapsules
- Scientific briefing: Dissolution development Parvulet technology with oral tablets
Related topics
Analytical techniques, Biopharmaceuticals, Excipients, Formulation, Good Manufacturing Practice (GMP), Ingredients, Manufacturing, Research & Development (R&D)
